Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
ConditionITP - Immune Thrombocytopenia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorAssiut University
About this trial
1. Assesement of response to Thrombopoietin receptor agonists (TPO-RAs) as treatment in Idiopathic thrombocytopenia purpura patients in Assiut University hospital. 2. Explore side effects of Thrombopoietin receptor agonists in Idiopathic thrombocytopenia purpura . 3. To study effect of thrombopoietin receptor agonists and Quality life in Idiopathic thrombocytopenia purpura patients.
Eligibility criteria
Qualifiers
Patients presented with Idiopathic thrombocytopenic purpura (ITP)
patients above age of 18 years.
Disqualifiers
patients below age of 18 years .
Trial design
Treatments tested in this trial
- eltrombopag and romiplastim
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Assiut University
Lead sponsor
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
Collaborator
Source ClinicalTrials.gov